...
首页> 外文期刊>Investigative ophthalmology & visual science >Quantitative Analyses of Retinal Vascular Area and Density After Different Methods to Reduce VEGF in a Rat Model of Retinopathy of Prematurity
【24h】

Quantitative Analyses of Retinal Vascular Area and Density After Different Methods to Reduce VEGF in a Rat Model of Retinopathy of Prematurity

机译:不同方法降低早产鼠视网膜病变模型后视网膜血管面积和密度的定量分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose.: Targeted inhibition of M??ller cell (MC)a??produced VEGF or broad inhibition of VEGF with an intravitreal anti-VEGF antibody reduces intravitreal neovascularization in a rat model of retinopathy of prematurity (ROP). In this study, we compared the effects of these two approaches on retinal vascular development and capillary density in the inner and deep plexi in the rat ROP model. Methods.: In the rat model of ROP, pups received 1 ??L of (1) subretinal lentivector-driven short hairpin RNA (shRNA) to knockdown MC-VEGFA (VEGFA.shRNA) or control luciferase shRNA, or (2) intravitreal anti-VEGF antibody (anti-VEGF) or control isotype goat immunoglobulin G (IgG). Analyses of lectin-stained flat mounts at postnatal day 18 (p18) included: vascular/total retinal areas (retinal vascular coverage) and pixels of fluorescence/total retinal area (capillary density) of the inner and deep plexi determined with the Syncroscan microscope, and angles between cleavage planes of mitotic vascular figures labeled with anti-phosphohistone H3 and vessel length. Results.: Retinal vascular coverage and density increased in both plexi between p8 and p18 in room air (RA) pups. Compared with RA, p18 ROP pups had reduced vascular coverage and density of both plexi. Compared with respective controls, VEGFA.shRNA treatment significantly increased vascular density in the deep plexus, whereas anti-VEGF reduced vascular density in the inner and deep plexi. Vascular endothelial growth factor-A.shRNA caused more cleavage angles predicting vessel elongation and fewer mitotic figures, whereas anti-VEGF treatment led to patterns of pathologic angiogenesis. Conclusions.: Targeted treatment with lentivector-driven VEGFA.shRNA permitted physiologic vascularization of the vascular plexi and restored normal orientation of dividing vascular cells, suggesting that regulation of VEGF signaling by targeted treatment may be beneficial.
机译:目的:用玻璃体内抗VEGF抗体靶向抑制M ller细胞(MC)αβ产生的VEGF或用VEGF广泛抑制VEGF可降低早产儿视网膜病变(ROP)大鼠模型的玻璃体内新血管形成。在这项研究中,我们比较了这两种方法对大鼠ROP模型中内,深丛的视网膜血管发育和毛细血管密度的影响。方法:在ROP大鼠模型中,幼犬接受1升(1)视网膜下慢病毒载体驱动的短发夹RNA(shRNA)敲低MC-VEGFA(VEGFA.shRNA)或对照荧光素酶shRNA,或(2)玻璃体内抗VEGF抗体(anti-VEGF)或对照同种型山羊免疫球蛋白G(IgG)。产后第18天(p18)对凝集素染色的平坦固定物的分析包括:通过Syncroscan显微镜确定的血管/总视网膜面积(视网膜血管覆盖)以及内部和深丛的荧光/总视网膜面积(毛细管密度)像素,标记有抗磷酸组蛋白H3的有丝分裂血管图形的切割平面之间的角度和血管长度。结果:在室内空气(RA)幼崽中,p8和p18之间的神经丛中视网膜血管覆盖率和密度均增加。与RA相比,p18 ROP幼崽的血管覆盖范围和两个丛的密度均降低。与相应的对照组相比,VEGFA.shRNA治疗显着增加了深丛的血管密度,而抗VEGF降低了内丛和深丛的血管密度。血管内皮生长因子-A.shRNA引起更多的分裂角预测血管伸长和更少的有丝分裂图,而抗VEGF治疗导致病理性血管生成的模式。结论:以慢病毒载体驱动的VEGFA.shRNA进行靶向治疗可以使血管丛的生理血管化并恢复分裂血管细胞的正常定向,这表明靶向治疗对VEGF信号传导的调节可能是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号